General Resources / Legal Resources / Medical Resources / Briefing Papers / State Activity    
Hospital Closures / Preventable Tragedies / Press Room / Search Our Site / Home

Archives of General Psychiatry

1994 (51): 826-836


Awareness of Illness in Schizophrenia and Schizoaffective and Mood Disorders
Amador XF, Flaum M, Andreasen NC, Strauss DH, Yale SA, Clark CC, & Gorman JM

RELEVANCE FOR EARLY INTERVENTION

The study reported in this paper involved over 400 patients from around the country and showed, unequivocally, that poor insight into illness is common in psychotic disorders while being rare in other psychiatric disorders. Large proportions of patients with schizophrenia, schizoaffective disorder, psychotic mania and psychotic depression were generally unaware of having an illness. This study is the first to also evaluate whether patients with these disorders were aware of the signs and symptoms of illness that they personally suffered from. Again, a very large proportion of patients in each of these four groups had no insight into the signs of the illness that they had despite the fact that they had been hospitalized in order to receive treatment for the very same symptoms that they were unaware of. The results of this study make it clear that many patients with these disorders lack the ability to recognize that they are ill and in need of medical care.


General Resources / Legal Resources / Medical Resources / Briefing Papers / State Activity   
Hospital Closures / Preventable Tragedies / Press Room / Search Our Site / Home

FootnoteImage2.jpg (1088 bytes)
Treatment Advocacy Center

The contents of all material available on the Center's website are copyrighted by the Treatment Advocacy Center unless otherwise indicated.  All rights reserved and content may be reproduced, downloaded, disseminated, or transferred, for single use, or by nonprofit organizations for educational purposes only, if correct attribution is made to the Treatment Advocacy Center.  Please feel free to call with questions on mental illness, treatment laws or the benefits of medication compliance at 703.294.6001 or send questions via email to [email protected].    Write to us at:  The Treatment Advocacy Center; 3300 N. Fairfax Drive; Suite 220; Arlington, VA  22201.  Technical comments on the Center's website (www.psychlaws.org) can be sent to [email protected]. The Treatment Advocacy Center is an I.R.C. � 501(c)(3) tax-exempt corporation.  Donations are appreciated and are eligible for the charitable contribution deduction under the provisions of I.R.C. � 170.